Cardiovascular Morbidity and Mortality After Amaurosis Fugax
This cohort study examines the risk of cardiovascular morbidity and mortality in patients with amaurosis fugax compared with a matched control group.
Authors
- Euna B. Koo (ORCID: https://orcid.org/0000-0003-4218-3338)
- Nathan H. Pham
- Prithvi Mruthyunjaya (ORCID: https://orcid.org/0000-0003-1087-9736)
- Karen M. Wai (ORCID: https://orcid.org/0000-0001-8980-2242)
- Chase A. Ludwig (ORCID: https://orcid.org/0000-0002-9586-3735)
- Ehsan Rahimy (ORCID: https://orcid.org/0000-0001-8446-7078)
- Deanne Kennedy Loube (ORCID: https://orcid.org/0000-0002-5159-2494)
Institutions
- University of Washington (US)
- Palo Alto Institute (US)
- Smith-Kettlewell Eye Research Institute (US)
- Stanford University (US)
Publication Details
- Journal
- JAMA Ophthalmology
- Published
- 2025-03-20
- DOI
- https://doi.org/10.1001/jamaophthalmol.2025.0249
- Citations
- 1
- Primary Topic
- Cerebrovascular and Carotid Artery Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.52